National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
米国
引用
ジャーナル: Cell Rep / 年: 2024 タイトル: Cholesterol reduction by immunization with a PCSK9 mimic. 著者: Baoshan Zhang / Gwo-Yu Chuang / Andrea Biju / Daniel Biner / Jiaxuan Cheng / Yiran Wang / Saran Bao / Cara W Chao / Haotian Lei / Tracy Liu / Alexandra F Nazzari / Yongping Yang / Tongqing ...著者: Baoshan Zhang / Gwo-Yu Chuang / Andrea Biju / Daniel Biner / Jiaxuan Cheng / Yiran Wang / Saran Bao / Cara W Chao / Haotian Lei / Tracy Liu / Alexandra F Nazzari / Yongping Yang / Tongqing Zhou / Steven J Chen / Xuejun Chen / Wing-Pui Kong / Li Ou / Danealle K Parchment / Edward K Sarfo / HaoMin SiMa / John-Paul Todd / Shuishu Wang / Ruth A Woodward / Cheng Cheng / Reda Rawi / John R Mascola / Peter D Kwong / 要旨: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a plasma protein that controls cholesterol homeostasis. Here, we design a human PCSK9 mimic, named HIT01, with no consecutive 9-residue ...Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a plasma protein that controls cholesterol homeostasis. Here, we design a human PCSK9 mimic, named HIT01, with no consecutive 9-residue stretch in common with any human protein as a potential heart attack vaccine. Murine immunizations with HIT01 reduce low-density lipoprotein (LDL) and cholesterol levels by 40% and 30%, respectively. Immunization of cynomolgus macaques with HIT01-K21Q-R218E, a cleavage-resistant variant, elicits high-titer PCSK9-directed antibody responses and significantly reduces serum levels of cholesterol 2 weeks after each immunization. However, HIT01-K21Q-R218E immunizations also increase serum PCSK9 levels by up to 5-fold, likely due to PCSK9-binding antibodies altering the half-life of PCSK9. While vaccination with a PCSK9 mimic can induce antibodies that block interactions of PCSK9 with the LDL receptor, PCSK9-binding antibodies appear to alter homeostatic levels of PCSK9, thereby confounding its vaccine impact. Our results nevertheless suggest a mechanism for increasing the half-life of soluble regulatory factors by vaccination.